Gonadorelin acetate NEW
Price | $28 |
Package | 1box |
Min. Order: | 1box |
Supply Ability: | 20000 |
Update Time: | 2024-05-15 |
Product Details
Product Name: Gonadorelin acetate | CAS No.: 34973-08-5 |
Min. Order: 1box | Purity: 99% |
Supply Ability: 20000 | Release date: 2024/05/15 |
Formula:C57H79N17O15
Molecular weight: 1242.342
Precise quality:1241.594116
PSA 509.43000
LogP 1.19830
Appearance, white or similar white powder
storage conditions: 2-8 ° C
Company Profile Introduction
Shanghai Getian Industrial Co.,Ltd is a leading enterprise committed to providing quality products and efficient logistics services. We are proud to introduce a range of products with excellent quality, and the industrial materials are subject to strict quality control to ensure that the high standards of our customers are met.
We have pharmaceutical raw material production factory and reagent research and development center. We now have a complete product line. In addition, we have developed and produced tens of thousands of reagents. We are complemented by a custom synthesis business of various organic compounds. We can synthesize almost any chemical.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$5.00/1Box |
VIP1Y
|
Hebei Jiafan Trading Company Limited
|
2024-12-24 | |
$20.00/1kg |
Shaanxi Franta Biotechnology Co., Ltd
|
2024-12-10 | ||
$0.00/1Box |
VIP1Y
|
American HealthyMorph LLC
|
2024-12-04 | |
$10.00/1KG |
VIP6Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-11-22 | |
$0.00/1box |
VIP1Y
|
Shandong Huizhihan Supply Chain Co., Ltd
|
2024-10-29 | |
$0.00/1ASSAYS |
VIP1Y
|
CONTIDE BIOTECH CO.,LTD
|
2024-10-17 | |
$0.00/1kg |
VIP2Y
|
Shandong Hanjiang Chemical Co., Ltd
|
2024-10-12 | |
$25.00/1Box |
VIP1Y
|
Qingdao Xinli Technology Development Co., Ltd.
|
2024-07-25 | |
$3.80/2mg |
VIP1Y
|
Hebei Ganmiao New material Technology Co., LTD
|
2024-06-27 | |
$0.00/1box |
VIP1Y
|
Shanghai Affida new material science and technology center
|
2024-05-28 |
- Since: 2024-01-19
- Address: Hong Kong
INQUIRY